| Stereochemistry | ABSOLUTE |
| Molecular Formula | C34H50O2 |
| Molecular Weight | 490.7596 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)C5=CC=CC=C5)[C@H](C)CCCC(C)C
InChI
InChIKey=UVZUFUGNHDDLRQ-LLHZKFLPSA-N
InChI=1S/C34H50O2/c1-23(2)10-9-11-24(3)29-16-17-30-28-15-14-26-22-27(36-32(35)25-12-7-6-8-13-25)18-20-33(26,4)31(28)19-21-34(29,30)5/h6-8,12-14,23-24,27-31H,9-11,15-22H2,1-5H3/t24-,27+,28+,29-,30+,31+,33+,34-/m1/s1
| Molecular Formula | C34H50O2 |
| Molecular Weight | 490.7596 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
There is no information in the scientific literature related to the biological and pharmacological properties of cholesteryl benzoate. Nevertheless, it is known, that initially it was used in some thermochromic liquid crystals. In addition, it can be used as an intermediate of vitamin D3 production, and in make-ups.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|